By integrating multiple disciplines centered on translational sciences, we can tether clinically impactful research to the enhancement of patient care.
Oncogenic Signatures
Develop genomic methods for predicting signaling network activation in normal, premalignant and tumor cells.
Breast Cancer Phenotypes
Determine breast cancer tumor phenotypes using multi-pathway and multi-omic modeling.
Tumor Heterogeneity
Investigate tumor evolution over the course of a patient’s treatment.
Bioinformatic Software
Develop tools for cancer detection and progression, multi-omic gene set enrichment analysis, and determining pathway activation levels.
Biomarkers
Develop of drug response biomarkers to match the right drug to each patient.
Clinical Trails
Initiate clinical that test the accuracy of genomic drug response biomarkers.